These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 36823403)

  • 1. Prenatal substance use in the rural and Appalachian state: Project WATCH study 2020-2022.
    Umer A; Garrow J; Nesbitt M; Lilly C; Lefeber C; Breyel J; John C
    J Rural Health; 2023 Sep; 39(4):804-815. PubMed ID: 36823403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Substance Exposure and Adverse Neonatal Outcomes: A Population-Based Cohort Study.
    Umer A; Watson E; Lilly C; Woods S; Lefeber C; Breyel J; John C
    J Pediatr; 2023 May; 256():70-76. PubMed ID: 36513212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychometric modeling of abuse and dependence symptoms across six illicit substances indicates novel dimensions of misuse.
    Clark SL; Gillespie NA; Adkins DE; Kendler KS; Neale MC
    Addict Behav; 2016 Feb; 53():132-40. PubMed ID: 26517709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contextual differences in substance use for rural Appalachian treatment-seeking women.
    Shannon LM; Havens JR; Mateyoke-Scrivner A; Walker R
    Am J Drug Alcohol Abuse; 2009; 35(2):59-62. PubMed ID: 19199165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends in Cannabis Polysubstance Use During Early Pregnancy Among Patients in a Large Health Care System in Northern California.
    Young-Wolff KC; Sarovar V; Tucker LY; Ansley D; Goler N; Conway A; Ettenger A; Foti TR; Brown QL; Kurtzman ET; Adams SR; Alexeeff SE
    JAMA Netw Open; 2022 Jun; 5(6):e2215418. PubMed ID: 35666502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.
    Paulozzi LJ; Strickler GK; Kreiner PW; Koris CM;
    MMWR Surveill Summ; 2015 Oct; 64(9):1-14. PubMed ID: 26469747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A national population-based study of cannabis use and correlates among U.S. veterans prescribed opioids in primary care.
    Zaman T; Bravata DM; Byers AL; Krebs EE; Leonard SJ; Sandbrink F; Barker W; Keyhani S
    BMC Psychiatry; 2023 Mar; 23(1):177. PubMed ID: 36927526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High Prevalence and Early Onsets: Legal and Illegal Substance Use in an Urban Cohort of Young Adults in Switzerland.
    Quednow BB; Steinhoff A; Bechtiger L; Ribeaud D; Eisner M; Shanahan L
    Eur Addict Res; 2022; 28(3):186-198. PubMed ID: 34864731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of and Factors Associated With Long-term Concurrent Use of Stimulants and Opioids Among Adults With Attention-Deficit/Hyperactivity Disorder.
    Wei YJ; Zhu Y; Liu W; Bussing R; Winterstein AG
    JAMA Netw Open; 2018 Aug; 1(4):e181152. PubMed ID: 30646105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Examining gender differences in substance use and age of first use among rural Appalachian drug users in Kentucky.
    Shannon LM; Havens JR; Oser C; Crosby R; Leukefeld C
    Am J Drug Alcohol Abuse; 2011 Mar; 37(2):98-104. PubMed ID: 21142705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conditional probabilities of substance use disorders and associated risk factors: Progression from first use to use disorder on alcohol, cannabis, stimulants, sedatives and opioids.
    Marel C; Sunderland M; Mills KL; Slade T; Teesson M; Chapman C
    Drug Alcohol Depend; 2019 Jan; 194():136-142. PubMed ID: 30439610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Individual and Combined Association Between Prenatal Polysubstance Exposure and Childhood Risk of Attention-Deficit/Hyperactivity Disorder.
    Garrison-Desany HM; Hong X; Maher BS; Beaty TH; Wang G; Pearson C; Liang L; Wang X; Ladd-Acosta C
    JAMA Netw Open; 2022 Mar; 5(3):e221957. PubMed ID: 35275164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substance use, socio-demographic characteristics, and self-rated health of people seeking alcohol and other drug treatment in New South Wales: baseline findings from a cohort study.
    Black E; Bruno R; Mammen K; Mills L; Siefried KJ; Deacon RM; Shakeshaft A; Dunlop AJ; Ezard N; Montebello M; Childs S; Reid D; Holmes J; Lintzeris N
    Med J Aust; 2023 Sep; 219(5):218-226. PubMed ID: 37449648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anxiety sensitivity and substance use: Differential levels across individuals primarily using opioids, cannabis, or stimulants.
    Raines AM; Ennis CR; Allan NP; McGrew SJ; Walton JL; Rogers AH; Zvolensky MJ; Schmidt NB; Laurel Franklin C
    Addict Behav; 2021 May; 116():106791. PubMed ID: 33497865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlates of concurrent use of stimulants and opioids among people who access harm reduction services in British Columbia, Canada: Findings from the 2019 Harm Reduction Client Survey.
    Lukac CD; Steinberg A; Papamihali K; Mehta A; Lock K; Buxton JA
    Int J Drug Policy; 2022 Apr; 102():103602. PubMed ID: 35124412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns of Substance Use During Early Pregnancy and Associations With Behavioral Health Characteristics.
    Sujan AC; Alexeeff SE; Slama N; Avalos LA; Adams SR; Conway A; Ansley D; Young-Wolff KC
    J Addict Med; 2023 May-Jun 01; 17(3):e141-e147. PubMed ID: 37267164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High prevalence of co-occurring substance use in individuals with opioid use disorder.
    Mahoney JJ; Winstanley EL; Lander LR; Berry JH; Marshalek PJ; Haut MW; Marton JL; Kimble WD; Armistead M; Wen S; Cai Y; Hodder SL
    Addict Behav; 2021 Mar; 114():106752. PubMed ID: 33348147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of Cannabis as a Harm Reduction Strategy Among People Who Use Drugs: A Cohort Study.
    Mok J; Milloy MJ; Grant C; Lake S; DeBeck K; Hayashi K; Kerr T; Socías ME
    Cannabis Cannabinoid Res; 2023 Aug; 8(4):670-678. PubMed ID: 35647886
    [No Abstract]   [Full Text] [Related]  

  • 19. Examining the heterogeneity of polysubstance use patterns in young adulthood by age and college attendance.
    Stevens AK; Gunn RL; Sokolovsky AW; Colby SM; Jackson KM
    Exp Clin Psychopharmacol; 2022 Oct; 30(5):701-713. PubMed ID: 33970653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring Patterns of the Use of Electronic Nicotine Delivery Systems among Adolescents in High-Risk Appalachian (U.S.A) Communities.
    Mamudu HM; Shahani D; Jones A; Ahuja M; Adeniran E; Weierbach F; Swindle J; Liu Y; Keener J; Blair CJ; McNabb M; Asare M; Wood DL; Ferketich A
    Subst Use Misuse; 2022; 57(2):167-174. PubMed ID: 34927538
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.